Edinburgh-headquartered angel investment syndicate Archangels has appointed Ian Macleod as the new chair of its board.
He takes over from Eric Young, who held the position since 2014 and will continue to sit on the board.
Macleod worked in London and Paris for many years as an analyst, specialising in the electronics and telecoms industries. He started with ANZ Capel Cure Myers and had spells at both NatWest Markets and Jeffries.
He then focussed on smaller tech, cleantech and biotech companies, moving into fund management with 360 Asset Managers and more recently Accessible Clean Energy.
Returning to Edinburgh in 2016, Macleod joined the Archangels board in 2018.
He said: “Archangels are at the forefront of that effort and it’s an honour to take on the role of chair.
“Under Eric’s chairmanship, Archangels has gone from strength to strength over the last eight years and I’m glad to keep his senior counsel on the board.
“I’m looking forward to supporting our portfolio businesses and investors, supporting entrepreneurialism and positively contributing to the Scottish economy.”
Young added: “With Ian’s long and highly successful career comes a great deal of experience and wisdom, all of which he will bring to the role of chair.
“Having worked with Ian since he joined the board in 2018, I am entirely confident that he is the right person to lead Archangels into the next exciting chapter of its growth."
Founded in 1992, Archangels claim's to be the world's longest running angel syndicate, investing in early-stage Scottish life sciences and technology companies.
Archangels comprises around 120 members and a five strong, full-time executive team.
In 2021, the syndicate invested £11.8m to reach a total of £23.6m including co-investment from Scottish Government agencies and other partners. There are currently 20 companies within the portfolio.
Don't miss the latest headlines with our twice-daily newsletter - sign up here for free.
